References
- Rodan, G.A., Martin, T.J. Therapeutic approaches to bone disease. Science 289: 1508-1514, 2000. https://doi.org/10.1126/science.289.5484.1508
- Clowes, J.A., Eghbali-Fatourechi, G.Z., McCready, L., Oursler, M.J., Khosla, S., Riggs, B.L. Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporos Int 20: 761-769, 2009. https://doi.org/10.1007/s00198-008-0731-y
- Mundy, G.R. Osteoporosis and inflammation. Nutr Rev 65: S147-S151, 2007. https://doi.org/10.1301/nr.2007.dec.S147-S151
- Boyle, W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 423: 337-342, 2003. https://doi.org/10.1038/nature01658
- Del Fattore A., Teti A., Rucci N. Osteoclast receptorsand signaling. Arch Biochem Biophys 473: 147-160, 2008. https://doi.org/10.1016/j.abb.2008.01.011
- Lee, Z.H., Kim, H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211-214, 2003. https://doi.org/10.1016/S0006-291X(03)00695-8
- Melton, L.J. 3rd, Atkinson, E.J., O'Connor, M.K., O'Fallon, W.M., Riggs, B. Bone density and fracture risk in men. J Bone Miner Res 13: 1915-1923, 1998. https://doi.org/10.1359/jbmr.1998.13.12.1915
- Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugal, N., Yamamoto, M., Nagata, N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18: 9-14, 1996. https://doi.org/10.1016/8756-3282(95)00426-2
- Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling,P.R. Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B., Shane, E. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22: 1479-1491, 2007. https://doi.org/10.1359/jbmr.0707onj
- 부일, 이제현, 최호영, 권동렬, 부영민. 韓藥本草學, 서울, 영림사 p 374; 375.
- Jeong, J.H., Jeong, J,C. Effects of Taxilli Ramulus Extract on Bone Metabolism of Ethanol Treated Rats. J Korean Oriental Med 22(4):1-9, 2001.
- David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H., Wagner, E.F. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci 115: 4317-4325, 2002. https://doi.org/10.1242/jcs.00082
- Chang, E.J., Ha, J., Huang, H., Kim, H.J., Woo, J.H., Lee, Y., Lee, Z.H., Kim, J.H., Kim, H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J Cell Sci 121: 2555-2564, 2008. https://doi.org/10.1242/jcs.028217
- Otero, J.E., Dai, S., Foglia, D., Alhawagri, M., Vacher, J., Pasparakis, M., Abu-Amer, Y. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem 283: 24546-24553, 2008. https://doi.org/10.1074/jbc.M800434200
- Ikeda, F., Matsubara, T., Tsurukai, T., Hata, K., Nishimura, R., Yoneda, T. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J Bone Miner Res 23: 907-914, 2008.
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901, 2002. https://doi.org/10.1016/S1534-5807(02)00369-6
- Eferl, R., Wagner, E.F. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003. https://doi.org/10.1038/nrc1209
- Wagner, E.F., Eferl, R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140, 2005. https://doi.org/10.1111/j.0105-2896.2005.00332.x
- Chelliaiah, M.A., Hruska, K.A. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72: 197-205, 2003. https://doi.org/10.1007/s00223-002-1025-6
- Zeng, Z., Zhang, C., Chen, J. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts. J Bone Miner Metab [Epub ahead of print], 2013.
- Ke, K., Kim, W.K., Sul, O.J., Phan, V.T., Lee, M.H., Kim, H.J., Kim, S.Y., Choi, H.S. Elevation of fibrinogen due to loss of ovarian function enhances actinring formation and leads to increased bone resorption. Am J Physiol Endocrinol Metab 303: E1296-E1303, 2012. https://doi.org/10.1152/ajpendo.00085.2012
- Tanaka, H., Tanabe, N., Kawato, T., Nakai, K., Kariya, T., Matsumoto, S., Zhao, N., Motohashi, M., Maeno, M. Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H(+)-ATPase d2 and Actin Organization in Osteoclasts. PLoS One 8: e59402, 2013. https://doi.org/10.1371/journal.pone.0059402
- Ichiro, N.., Naoyuki, T., Takahisa, S., Eijiro, J., Takahide, K., Tatsuo S. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res 11: 1873-1879, 1996.